The effects of the new structural analogue of benactyzine, a derivative of fluorencarbonic acid, on monoamine levels in brain structures were studied in male Wistar rats with experimental depression. Depressive state in rats was modeled by single injection of reserpine (4 mg/kg). The concentrations of norepinephrine (NE), dopamine (DA), serotonin (5-HT), and their metabolites 3,4-dihydroxyphenylacetic acid (DOPAC), homovanilic acid (HVA), and 5-hydroxyindoleacetic acid (5-HIAA) in the hypothalamus and striatum were measured by HPLC. It was found that preliminary treatment (30 days) with the derivative of fluorencarbonic acid prevented a decrease in monoamine level in the hypothalamus (NE, 5-HT, and 5-HIAA) and striatum (DA, 5-HT, and 5-HIAA). The neurochemical shifts (correction of 5-HT deficiency and stabilization of DA and NE levels) correlated with the high antidepressant activity of this agent observed in Porsolt forced swimming test.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Voronkov DN, Dovedova EL, Khudoerkov RM. Interactions between neurotransmitter systems in nigrostriatal structures of rat brain after long-term administration of reserpine and haloperidol. Neurochem. J. 2012;6(2):116-120.
WHO Fact sheet No. 369. Depression. [URL: http://who.int/mediacentre/factsheets/fs369/ru/].
Kudrin VS, Mosin VM, Klodt PM, Narkevich VB, Molodavkin GM, Voronina TA. Studying effects of amitriptyline, fluoxetine, and tianeptine on the content of monoamines and their metabolites in Wistar rat brain structures. Eksp. Klin. Farmakol. 2010;73(3):7-10. Russian.
Losev NA, Sapronov NS, Khnychenkp LK, Shabanov PD. Pharmacology of Novel Cholinergic Preparations (Pharmacology for Clinical Practice). St. Petersburg, 2015. Russian.
Loseva EV, Sarkisova KY, Loginova NA, Kudrin VS. Depressive behavior and monoamine contents in brain structures of rats during chronic overcrowding. Bull. Exp. Biol. Med. 2015;159(3):327-330.
Mashkovskii VM. Drugs. Moscow, 2014. Russian.
Losev NA, Jakovleva EE, Khychenko NS, Sapronov NS, Shabanov PD. Patent RF No. 2535027. Antidepressant. Bull. No. 34. Published December 10, 2014.
Manual for Preclinical Studies of New Pharmacological Substances. Part I, Mironov AN, ed. Moscow, 2012. Russian.
Chaudhury D, Liu H, Han MH. Neuronal correlates of depression. Cell. Mol. Life Sci. 2015;72(24):4825-4848.
Crawford AA, Lewis S, Nutt D, Peters TJ, Cowen P, O’Donovan MC, Wiles N, Lewis G. Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals. Psychopharmacology (Berl). 2014;231(15):2921-2931.
Delgado PL. Depression: the case a monoamine deficiency. J. Clin. Psychiatry. 2000;61(Suppl 6):7-11.
Fitzgerald PJ. Black bile: are elevated monoamines an etiological factor in some cases of major depression? Med. Hypotheses. 2013;80(6):823-826.
Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008;455:894-902.
Mathew SJ, Manji HK, Charney DS. Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology. 2008;33(9):2080-2092.
Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. Pharmacol. 1978;47(4):379-391.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 163, No. 5, pp. 587-590, May, 2017
Rights and permissions
About this article
Cite this article
Khnychenko, L.K., Yakovleva, E.E., Bychkov, E.R. et al. Effects of Fluorencarbonic Acid Derivative on the Levels of Monoamines and Their Metabolites in Brain Structures of Rats with Modeled Depression-Like State. Bull Exp Biol Med 163, 632–634 (2017). https://doi.org/10.1007/s10517-017-3866-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-017-3866-z